---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-049485"
form_type: "8-K"
ticker: "PAHC"
cik: "0001069899"
company_name: "PHIBRO ANIMAL HEALTH CORP"
filed_at: "2026-04-27T23:59:59+00:00"
generated_at: "2026-05-15T03:42:36.968967+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Brazilian MAPA bans Phibro's virginiamycin and bacitracin growth promoters; 180-day transition

## Summary
- MAPA Ordinance 1617 prohibits import, manufacture, marketing and use of antimicrobial feed additives including virginiamycin and bacitracin for growth promotion.
- Transition period of 180 days from April 27, 2026; products can still be sold under current labels during that time.
- Phibro expects new therapeutic registrations for virginiamycin in cattle and broilers during transition; bacitracin already has therapeutic claims.
- Company expects limited impact on fiscal year 2026 results; also launching PhibroVet digital prescription platform.
- Additional details to be provided on May 7, 2026 earnings call.

## SEC filing metadata
- accession: 0001104659-26-049485
- form_type: 8-K
- ticker: PAHC
- cik: 0001069899
- company_name: PHIBRO ANIMAL HEALTH CORP
- filed_at: 2026-04-27T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069899/000110465926049485/0001104659-26-049485-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069899/000110465926049485/tm2612861d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-049485
- JSON: https://secwatch.observer/filing/0001104659-26-049485.json
- Plain text: https://secwatch.observer/filing/0001104659-26-049485.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.